Page 1

REVENIO Revenio updates its strategy for 2027-2029 and provides new financial targets for the strategy period Revenio Group Corporation | Stock Exchange Release | September 15 , 2026 at 09:00:00 EEST As previously announced , Revenio has undergone a strategic review after the completion of the Visionix acquisition . Revenio's Board of Directors has today approved the company's updated strategy for 2027-2029 , along with new financial targets for the strategy period . Revenio's strategy for 2027-2029 – Leading the shift from vision care to connected eye health Revenio is one of the leading turnkey solutions providers in the global eye care market . Revenio's addressable market in ophthalmic diagnostic equipment is roughly USD 2.7 billion , with growth supported by powerful megatrends and changing industry dynamics . The need for eye care continues to grow globally , driven by ageing population and increase in lifestyle related diseases , putting pressure on already limited healthcare resources . To help address gaps in eye care capacity , optical retail and optometry are expanding their role in screening and diagnostics , expanding the access to care . This shift means that intelligent eye care systems that improve efficiency , support clinical decision - making and enable earlier diagnosis are becoming increasingly important . Based on the market development , Revenio's updated strategy focuses on leading the shift from vision care to connected eye health . By joining forces with Visionix in 2026 , Revenio significantly broadened its offering and customer reach , particularly in vision care solutions for optical retail , complementing its established presence in diagnostic solutions for optometry and ophthalmology . The combined portfolio covers the entire patient journey from refraction and screening to advanced diagnostics , helping eye care professionals deliver high - quality care more efficiently and across a broader range of care settings . This provides a strong foundation for Revenio to reach more customers , offer more solutions and lead the shift toward connected eye health . The strategy and its execution are based on four cornerstones : • Advance Clinical Confidence and Workflow Excellence through connected product innovations and workflows that help customers deliver better eye care • Drive Commercial Excellence through customer - focused go - to - market • Scale Operational Excellence with uncompromising quality • Develop People & Culture as a foundational strength Revenio Group Corporation | Äyritie 22 | FI - 01510 Vantaa